|
Subject characteristics. Individual characteristics of subjects used in this study. Subjects are numbered by the order of first blood collection. Some subjects had 2 or 3 blood draws. Recurrence rates are based on patients recollection and were divided into groups of low recurrence rates (L) of 2 or fewer per year and high recurrence rates (H) for subjects that stated having more than 2 recurrences a year. Positive designation for antivirals are those patients that were using antivirals at the time of blood draw. To determine serostatus the HerpeSelect 1 & 2 immunoblot kit from Focus technologies was used. Patient 4 is a double negative. Subjects 6 and 15 were using acyclovir and subject 11 was using daily doses of Valtrex. |
|||||
| Subject |
Sex |
Age |
Antiviral |
Recurrence rate |
Serostatus |
|
|
|||||
| 1 |
M |
37 |
- |
H |
HSV-2/HSV-1 |
| 2 |
F |
38 |
- |
L |
HSV-2/HSV-1 |
| 3 |
F |
47 |
- |
H |
HSV-2/HSV-1 |
| 4 |
M |
29 |
- |
na |
- |
| 5 |
M |
34 |
- |
H |
HSV-2/HSV-1 |
| 6 |
F |
49 |
+ |
H |
HSV-2 |
| 7 |
F |
22 |
- |
L |
HSV-1 |
| 8 |
F |
42 |
- |
H |
HSV-2 |
| 9 |
F |
24 |
- |
L |
HSV-2 |
| 10 |
F |
19 |
- |
L |
HSV-1 |
| 11 |
F |
29 |
+ |
L |
HSV-2/HSV-1 |
| 12 |
M |
28 |
- |
H |
HSV-2 |
| 13 |
F |
40 |
- |
L |
HSV-2 |
| 14 |
F |
38 |
- |
H |
HSV-2 |
| 15 |
M |
59 |
+ |
H |
HSV-2/HSV-1 |
| 16 |
F |
45 |
- |
L |
HSV-2 |
| 17 |
M |
27 |
- |
L |
HSV-1 |
| 18 |
M |
53 |
- |
L |
HSV-2 |
Braun et al. Virology Journal 2006 3:54 doi:10.1186/1743-422X-3-54 |
|||||